IL-31 induces antitumor immunity in breast carcinoma.
Tal KanErik FeldmanMichael TimanerZiv RavivShai Shen-OrrAmi AronheimYuval ShakedPublished in: Journal for immunotherapy of cancer (2021)
Our findings demonstrate that IL-31 induces antitumor immunity, highlighting its potential utility as a therapeutic immunomodulatory agent.
Keyphrases